Hans Eriksson obtained his MD and PhD in Cell and Molecular Biology at Lund University in Sweden. He also holds an Executive MBA from Stockholm School of Economics. After clinical training in psychiatry, he served as Consultant Psychiatrist and Assisting Head of the Psychiatric Clinic at Lund University Hospital. During the last two decades, he has held several senior clinical development roles in the pharmaceutical industry, in Sweden, Denmark, USA, and the UK. He has worked on five late-phase clinical development programmes for depression indications, three of which have resulted in regulatory approvals for Major Depressive Disorder.
In his role as Chief Clinical Development Officer, Hans leads the clinical programmes at Brain Health, ensuring that the strategies are aligned with the promises of the compounds in development.
Sign up to view 2 direct reports
Get started